Browse by author
Lookup NU author(s): Dr Jane Renwick, Professor Gareth Veal, Dr Chris RedfernORCiD, Professor Penny Lovat
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Fenretinide-induced apoptosis of neuroectodermal tumour cells is mediated through generation of reactive oxygen species (ROS), endoplasmic reticulum (ER) stress, mitochondrial cytochrome c release and caspase activation. The present study describes the requirement of the BH3-domain only protein Noxa for this process and its regulation by p53. Noxa expression was induced by fenretinide in neuroblastoma and melanoma cells, including those with mutated p53, and this induction was abolished by antioxidants. Knockdown of p53 by RNA interference (RNAi) demonstrated upregulation of Noxa protein levels in response to fenretinide was p53-independent, although evidence suggested that Noxa may be transcriptionally regulated by p53. The ER stress-inducing agent thapsigargin also induced p53-independent Noxa expression. Conversely, Noxa transcription in response to the chemotherapeutic agents cisplatin or temozolomide was inhibited by p53 knockdown. Apoptosis in response to cisplatin or temozolomide was also inhibited by abrogation of p53 expression yet apoptosis in response to fenretinide or thapsigargin was unaffected. RNAi-mediated down-regulation of Noxa inhibited apoptosis in response to fenretinide or thapsigargin, whereas apoptosis induced by cisplatin or temozolomide was unaffected. These data demonstrate the importance of Noxa induction in determining the apoptotic response to fenretinide and emphasise the role of Noxa in p53-independent apoptosis. © 2006 Springer Science+Business Media, LLC.
Author(s): Armstrong, J.L., Veal, G.J., Redfern, C.P.F., Lovat, P.E.
Publication type: Article
Publication status: Published
Journal: Apoptosis
Year: 2007
Volume: 12
Issue: 3
Pages: 613-622
Print publication date: 01/03/2007
ISSN (print): 1360-8185
ISSN (electronic): 1573-675X
URL: http://dx.doi.org/10.1007/s10495-006-0020-1
DOI: 10.1007/s10495-006-0020-1
PubMed id: 17216584
Altmetrics provided by Altmetric
